Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Revital Levy

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Immunology Letters|May 15, 2002
Superantigen concomitantly induces Th1 cytokine genes and the ability to shut off their expression on re-exposure to superantigenGila Arad, Revital Levy, Raymond Kaempfer
Immunology Letters|March 17, 2004
Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptideGila Arad, Dalia Hillman, Revital Levy, et al.
The Israel Medical Association Journal : IMAJ|July 18, 2002
Defense against biologic warfare with superantigen toxinsRaymond Kaempfer, Gila Arad, Revital Levy, et al.
Toxins|September 12, 2013
CD28: direct and critical receptor for superantigen toxinsRaymond Kaempfer, Gila Arad, Revital Levy, et al.
Receptors & Clinical Investigation|March 14, 2017
Bacterial superantigen toxins induce a lethal cytokine storm by enhancing B7-2/CD28 costimulatory receptor engagement, a critical immune checkpointRaymond Kaempfer, Andrey Popugailo, Revital Levy, et al.
Genome Biology|November 28, 2023
Methylation-directed regulatory networks determine enhancing and silencing of mutation disease driver genes and explain inter-patient expression variationYifat Edrei, Revital Levy, Daniel Kaye, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2016
Superantigens hyperinduce inflammatory cytokines by enhancing the B7-2/CD28 costimulatory receptor interactionRevital Levy, Ziv Rotfogel, Dalia Hillman, et al.
Plos Genetics|February 18, 2016
Embryonic Stem Cell (ES)-Specific Enhancers Specify the Expression Potential of ES Genes in CancerDvir Aran, Monther Abu-Remaileh, Revital Levy, et al.
Journal of Biomedical Science|June 28, 2023
The homodimer interfaces of costimulatory receptors B7 and CD28 control their engagement and pro-inflammatory signalingAndrey Popugailo, Ziv Rotfogel, Michal Levy, et al.
Frontiers in Immunology|September 7, 2021
Binding of Staphylococcal Enterotoxin B (SEB) to B7 Receptors Triggers TCR- and CD28-Mediated Inflammatory Signals in the Absence of MHC Class II MoleculesMartina Kunkl, Carola Amormino, Silvana Caristi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Immunology Letters|May 15, 2002
Superantigen concomitantly induces Th1 cytokine genes and the ability to shut off their expression on re-exposure to superantigenGila Arad, Revital Levy, Raymond Kaempfer
Immunology Letters|March 17, 2004
Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptideGila Arad, Dalia Hillman, Revital Levy, et al.
The Israel Medical Association Journal : IMAJ|July 18, 2002
Defense against biologic warfare with superantigen toxinsRaymond Kaempfer, Gila Arad, Revital Levy, et al.
Toxins|September 12, 2013
CD28: direct and critical receptor for superantigen toxinsRaymond Kaempfer, Gila Arad, Revital Levy, et al.
Receptors & Clinical Investigation|March 14, 2017
Bacterial superantigen toxins induce a lethal cytokine storm by enhancing B7-2/CD28 costimulatory receptor engagement, a critical immune checkpointRaymond Kaempfer, Andrey Popugailo, Revital Levy, et al.
Genome Biology|November 28, 2023
Methylation-directed regulatory networks determine enhancing and silencing of mutation disease driver genes and explain inter-patient expression variationYifat Edrei, Revital Levy, Daniel Kaye, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2016
Superantigens hyperinduce inflammatory cytokines by enhancing the B7-2/CD28 costimulatory receptor interactionRevital Levy, Ziv Rotfogel, Dalia Hillman, et al.
Plos Genetics|February 18, 2016
Embryonic Stem Cell (ES)-Specific Enhancers Specify the Expression Potential of ES Genes in CancerDvir Aran, Monther Abu-Remaileh, Revital Levy, et al.
Journal of Biomedical Science|June 28, 2023
The homodimer interfaces of costimulatory receptors B7 and CD28 control their engagement and pro-inflammatory signalingAndrey Popugailo, Ziv Rotfogel, Michal Levy, et al.
Frontiers in Immunology|September 7, 2021
Binding of Staphylococcal Enterotoxin B (SEB) to B7 Receptors Triggers TCR- and CD28-Mediated Inflammatory Signals in the Absence of MHC Class II MoleculesMartina Kunkl, Carola Amormino, Silvana Caristi, et al.
Pageof 2